Eiger BioPharmaceuticals ... (EIGR)
NASDAQ: EIGR
· Real-Time Price · USD
1.73
0.00 (0.29%)
At close: Apr 03, 2024, 3:59 PM
Eiger BioPharmaceuticals Revenue
Eiger BioPharmaceuticals reported an annual revenue of $15.77M, reflecting a 16.98% growth. For the quarter ending December 31, 2023, Eiger BioPharmaceuticals generated $3.8M in revenue.
Revenue (ttm)
$15.77M
Revenue Growth
16.98%
Price / Sales Ratio
0.63
Revenue / Employee
$281.66K
Employees
56
Market Cap
2.55M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | % Change |
---|